Radionuclide evaluation of renal transplants.
In this review article, the following topics are treated: the radiopharmaceuticals 99mTc-diethylenetriaminepentaacetic acid (DTPA), 131I-orthoiodohippurate (OIH), 99mTc-mercaptoacetyltriglycine (MAG3), 67Ga-citrate, radioiodinated fibrinogen, 99mTc-sulfur colloid, 111In-labelled white cells and platelets; gamma camera methods based on images, on first pass and on tubular transit; blood clearance methods; and the diagnosis of surgical complications, acute rejection (AR), acute tubular necrosis (ATN), chronic rejection (CR), and cyclosporine-A (CYA) toxicity.
Dubovsky
E V
EV
Division of Nuclear Medicine, University of Alabama, Birmingham Medical Center.
Russell
C D
CD
D006084:Graft Rejection; D006801:Humans; D007465:Iodohippuric Acid; D007668:Kidney / Q000000981:diagnostic imaging; D016030:Kidney Transplantation; D009842:Oligopeptides; D009942:Organometallic Compounds; D004369:Pentetic Acid; D011183:Postoperative Complications; D011877:Radionuclide Imaging; D013667:Technetium; D017263:Technetium Tc 99m Mertiatide; D016284:Technetium Tc 99m Pentetate; D014184:Transplantation, Homologous / Q000009:adverse effects
D009842:Oligopeptides; D009942:Organometallic Compounds; D007465:Iodohippuric Acid; D017263:Technetium Tc 99m Mertiatide; D013667:Technetium; D004369:Pentetic Acid; D016284:Technetium Tc 99m Pentetate